Foghorn Therapeutics Inc (FHTX)
7.84
+0.12
(+1.55%)
USD |
NASDAQ |
Nov 22, 16:00
7.84
0.00 (0.00%)
After-Hours: 20:00
Foghorn Therapeutics Shareholders Equity (Quarterly): -28.29M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -28.29M |
| June 30, 2024 | -14.32M |
| March 31, 2024 | -97.49M |
| December 31, 2023 | -77.19M |
| September 30, 2023 | -57.39M |
| June 30, 2023 | -49.35M |
| March 31, 2023 | -24.59M |
| December 31, 2022 | 0.112M |
| September 30, 2022 | 24.32M |
| June 30, 2022 | 47.63M |
| Date | Value |
|---|---|
| March 31, 2022 | 72.40M |
| December 31, 2021 | 96.87M |
| September 30, 2021 | 80.98M |
| June 30, 2021 | 104.19M |
| March 31, 2021 | 125.16M |
| December 31, 2020 | 146.19M |
| September 30, 2020 | -133.32M |
| June 30, 2020 | 18.11M |
| December 31, 2019 | -88.02M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-133.32M
Minimum
Sep 2020
146.19M
Maximum
Dec 2020
7.686M
Average
0.112M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Sana Biotechnology Inc | 292.48M |
| Omega Therapeutics Inc | 11.54M |
| Moderna Inc | 11.93B |
| United Therapeutics Corp | 6.101B |
| CEL-SCI Corp | 8.473M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 308.37M |
| Total Liabilities (Quarterly) | 336.66M |
| Current Ratio | 4.773 |